BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23416164)

  • 1. The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma.
    Lichner Z; Scorilas A; White NM; Girgis AH; Rotstein L; Wiegand KC; Latif A; Chow C; Huntsman D; Yousef GM
    Am J Pathol; 2013 Apr; 182(4):1163-70. PubMed ID: 23416164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma.
    Chowdhury B; Porter EG; Stewart JC; Ferreira CR; Schipma MJ; Dykhuizen EC
    PLoS One; 2016; 11(4):e0153718. PubMed ID: 27100670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinoma.
    Jiang W; Dulaimi E; Devarajan K; Parsons T; Wang Q; O'Neill R; Solomides C; Peiper SC; Testa JR; Uzzo R; Yang H
    Oncotarget; 2017 Jun; 8(23):37423-37434. PubMed ID: 28445125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of Fibrinogen-Like Protein 2 is associated with poor prognosis in patients with clear cell renal cell carcinoma.
    Tang M; Cao X; Li P; Zhang K; Li Y; Zheng QY; Li GQ; Chen J; Xu GL; Zhang KQ
    Sci Rep; 2017 Oct; 7(1):12676. PubMed ID: 28978925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive molecular characterization of clear cell renal cell carcinoma.
    Cancer Genome Atlas Research Network
    Nature; 2013 Jul; 499(7456):43-9. PubMed ID: 23792563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice.
    Mathur R; Alver BH; San Roman AK; Wilson BG; Wang X; Agoston AT; Park PJ; Shivdasani RA; Roberts CW
    Nat Genet; 2017 Feb; 49(2):296-302. PubMed ID: 27941798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma.
    Hakimi AA; Mano R; Ciriello G; Gonen M; Mikkilineni N; Sfakianos JP; Kim PH; Motzer RJ; Russo P; Reuter VE; Hsieh JJ; Ostrovnaya I
    J Urol; 2014 Jul; 192(1):24-9. PubMed ID: 24518768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARID1A loss activates MAPK signaling via DUSP4 downregulation.
    Mandal J; Yu ZC; Shih IM; Wang TL
    J Biomed Sci; 2023 Dec; 30(1):94. PubMed ID: 38071325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered regulation of DPF3, a member of the SWI/SNF complexes, underlies the 14q24 renal cancer susceptibility locus.
    Colli LM; Jessop L; Myers TA; Camp SY; Machiela MJ; Choi J; Cunha R; Onabajo O; Mills GC; Schmid V; Brodie SA; Delattre O; Mole DR; Purdue MP; Yu K; Brown KM; Chanock SJ
    Am J Hum Genet; 2021 Sep; 108(9):1590-1610. PubMed ID: 34390653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Landscape of chromatin remodeling gene alterations in endometrial carcinoma.
    Momeni-Boroujeni A; Vanderbilt C; Yousefi E; Abu-Rustum NR; Aghajanian C; Soslow RA; Ellenson LH; Weigelt B; Murali R
    Gynecol Oncol; 2023 May; 172():54-64. PubMed ID: 36958196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of ARID1A mutations with mRNA levels and protein expression in gastric carcinoma.
    Hwang I; Cho Y; Kang SY; Kim DG; Ahn S; Lee J; Kim KM
    Pathol Res Pract; 2024 Mar; 255():155063. PubMed ID: 38324965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array.
    Boer JM; Huber WK; Sültmann H; Wilmer F; von Heydebreck A; Haas S; Korn B; Gunawan B; Vente A; Füzesi L; Vingron M; Poustka A
    Genome Res; 2001 Nov; 11(11):1861-70. PubMed ID: 11691851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma.
    Arseneault M; Monlong J; Vasudev NS; Laskar RS; Safisamghabadi M; Harnden P; Egevad L; Nourbehesht N; Panichnantakul P; Holcatova I; Brisuda A; Janout V; Kollarova H; Foretova L; Navratilova M; Mates D; Jinga V; Zaridze D; Mukeria A; Jandaghi P; Brennan P; Brazma A; Tost J; Scelo G; Banks RE; Lathrop M; Bourque G; Riazalhosseini Y
    Sci Rep; 2017 Mar; 7():44876. PubMed ID: 28332632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of ARID1A-interacting proteins in renal tubular cells and their molecular regulation of angiogenesis.
    Yoodee S; Peerapen P; Plumworasawat S; Malaitad T; Thongboonkerd V
    J Transl Med; 2023 Nov; 21(1):862. PubMed ID: 38017409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma.
    Alchahin AM; Mei S; Tsea I; Hirz T; Kfoury Y; Dahl D; Wu CL; Subtelny AO; Wu S; Scadden DT; Shin JH; Saylor PJ; Sykes DB; Kharchenko PV; Baryawno N
    Nat Commun; 2022 Sep; 13(1):5747. PubMed ID: 36180422
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Szarkowska J; Cwiek P; Szymanski M; Rusetska N; Jancewicz I; Stachowiak M; Swiatek M; Luba M; Konopinski R; Kubala S; Zub R; Kucharz J; Wiechno P; Siedlecki JA; Markowicz S; Sarnowska E; Sarnowski TJ
    Am J Cancer Res; 2021; 11(12):5965-5978. PubMed ID: 35018236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors.
    Young MD; Mitchell TJ; Vieira Braga FA; Tran MGB; Stewart BJ; Ferdinand JR; Collord G; Botting RA; Popescu DM; Loudon KW; Vento-Tormo R; Stephenson E; Cagan A; Farndon SJ; Del Castillo Velasco-Herrera M; Guzzo C; Richoz N; Mamanova L; Aho T; Armitage JN; Riddick ACP; Mushtaq I; Farrell S; Rampling D; Nicholson J; Filby A; Burge J; Lisgo S; Maxwell PH; Lindsay S; Warren AY; Stewart GD; Sebire N; Coleman N; Haniffa M; Teichmann SA; Clatworthy M; Behjati S
    Science; 2018 Aug; 361(6402):594-599. PubMed ID: 30093597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids.
    Fernandez-Cuesta L; Peifer M; Lu X; Sun R; Ozretić L; Seidal D; Zander T; Leenders F; George J; Müller C; Dahmen I; Pinther B; Bosco G; Konrad K; Altmüller J; Nürnberg P; Achter V; Lang U; Schneider PM; Bogus M; Soltermann A; Brustugun OT; Helland Å; Solberg S; Lund-Iversen M; Ansén S; Stoelben E; Wright GM; Russell P; Wainer Z; Solomon B; Field JK; Hyde R; Davies MP; Heukamp LC; Petersen I; Perner S; Lovly C; Cappuzzo F; Travis WD; Wolf J; Vingron M; Brambilla E; Haas SA; Buettner R; Thomas RK
    Nat Commun; 2014 Mar; 5():3518. PubMed ID: 24670920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-cell exome sequencing identifies mutations in KCP, LOC440040, and LOC440563 as drivers in renal cell carcinoma stem cells.
    Li C; Wu S; Yang Z; Zhang X; Zheng Q; Lin L; Niu Z; Li R; Cai Z; Li L
    Cell Res; 2017 Apr; 27(4):590-593. PubMed ID: 27981968
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of ARID1A mutation in gastric cancer and its significance for treatment.
    Lu S; Duan R; Cong L; Song Y
    Cancer Cell Int; 2023 Nov; 23(1):296. PubMed ID: 38008753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.